The Global Antivenom Market is expected to reach USD 1,493.2 million by 2021 from USD 1,109.5 million in 2016, growing at a CAGR of 6.12% during the forecast period 2016-2021. Antivenom is described as the biological product that detoxifies poisoning of venomous bites. Antivenom is prepared from the milking venom of animals such as snakes, spiders, scorpions, and other venomous animals. Venomous bites result in certain clinical conditions such as secretion of excessive saliva, muscle weakness, breathing problems, and other difficulties that may lead to death also. It is estimated that, approximately 100,000 people die worldwide with snake bites annually. To overcome poisonous effects after venomous bites the global manufacturers developed number of Antivenom products including vaccines and hyperimmune sera.
Increasing government initiations to promote the development of high quality antivenom products, presence of highest number of snake bite victims (especially from Asia & Africa regions), and estimated pipeline products launch are driving the growth of global Antivenom Market. In addition, growing of deaths from venomous animal’s bites and increasing research to develop advanced antivenom products are further stimulating the growth of global Antivenom Market. However, withdrawal of antivenom products, Lack of regulatory capacity for control of anti-venom, high cost of the products are restraining the growth of global Antivenom Market.
The Global market for Antivenom is broadly categorized by Animal Type, Antivenom type and Hyperimmune Sera. On the basis of Antivenom type, the market is segmented into monovalent, bivalent, trivalent, tetravalent and polyvalent products. Based on animal the market is segmented into Snakes, Scorpions, Spiders, and Others. Based on Hyperimmune Sera the market is segmented as Homologous and Heterologous antivenoms.
On the basis of geography, the global market is analysed under various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. North America is the dominating market for Antivenom followed by Europe in 2016.
Key market players in the global Antivenom market include CSL Limited (Australia), BTG Plc (U.K.), Merck & Co., Inc. (U.S.), PT Bio Farma, Incepta Vaccine Ltd. (Bangladesh), Instituto Bioclon, S.A. de C.V. (Mexico), Bharat Serum and Vaccines Limited (BSV) (India), Instituto Butantan, Rare Disease Therapeutics, Inc. (U.S.) and Vins Bioproducts Limited (India).
Request a Sample of Report @ http://www.orbisresearch.com/contacts/request-sample/255806
The Middle-East and Africa safety syringes market can be categorized on the basis of technology into Retractable and Non-Retractable safety syringes. The retractable syringes market is sub-segmented into Automatic or Manual syringes. And the non-retractable safety syringes are sub-segmented into sliding needle cover syringes, sheathing tube syringes, and hinged needle cover syringes. Non-retractable safety syringes hold the major share of sales in the Middle-East and Africa regions while the retractable safety syringes segment is anticipated to rise at a higher CAGR within the forecast period. Furthermore, on the basis of therapy, the safety syringes market can be categorized under Insulin, Tuberculosis, Glucagon-like peptide-1 (GLP-1) and Growth Hormones. Moreover, taking into account end users, the Middle-East and Africa safety syringe market is branded under hospitals and home care segments.
On the basis of geography, the Middle-East and Africa safety syringe market is segmented and analysed under various countries namely, UAE, Saudi Arabia, South Africa and Qatar. Middle-East and Africa regions are showing high potential for growth mainly owing to the populace strength. African countries have the high incidence of diseases duo to unsafe injection practices. With proper organization of awareness programs about safety syringes in these regions can create an ample opportunity for the companies to capitalize on, provided they come in affordable prices.
Some of the major companies operating in the Middle-East and Africa safety syringes market are Retractable Technologies, Inc, Covidien plc, Terumo Corporation, Unilife Corporation, Revolutions Medical Corporation, Becton, Dickinson & Company, Smiths Medical, Axel Bio Corporation, Sol-Millennum and Ultimed, In.
Enquire Before Buying Report @ http://www.orbisresearch.com/contacts/enquiry-before-buying/255806
Some Points From Table Of Content :
MARKET SEGMENTATION :
Global Antivenom Market, By Animal Type
Global Antivenom Market, By Antivenom Type
Global Antivenom Market, By Hyperimmune Sera
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Email ID: email@example.com